11:51 AM EDT, 07/16/2024 (MT Newswires) -- BioXcel Therapeutics ( BTAI ) shares rose more than 5% in recent Tuesday trading after the company said it expects Q2 revenue of about $1.1 million, up about 141% from a year earlier.

Analysts polled by Capital IQ expect $800,000.

The company said revenue grew due to an increase in contracting with psychiatric care clinics and behavioral health facilities.

Price: 1.29, Change: +0.07, Percent Change: +5.33